Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Enzyme Replacement Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Enzyme Replacement Therapy Market, by Product, 2019-2029 (USD Billion)
1.2.3. Enzyme Replacement Therapy Market, by Disease, 2019-2029 (USD Billion)
1.2.4. Enzyme Replacement Therapy Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Enzyme Replacement Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Enzyme Replacement Therapy Market Dynamics
3.1. Enzyme Replacement Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of rare diseases
3.1.1.2. Availability of a wide range of enzyme replacement therapy
3.1.2. Market Challenges
3.1.2.1. High cost of treatment
3.1.3. Market Opportunities
3.1.3.1. Rising public awareness about enzyme replacement therapies
Chapter 4. Global Enzyme Replacement Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Enzyme Replacement Therapy Market, by Product
6.1. Market Snapshot
6.2. Global Enzyme Replacement Therapy Market by Product, Performance - Potential Analysis
6.3. Global Enzyme Replacement Therapy Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Enzyme Replacement Therapy Market, Sub Segment Analysis
6.4.1. Agalsidase Beta
6.4.2. Imiglucerase
6.4.3. Velaglucerase Alfa
6.4.4. Idursulfase
6.4.5. Galsulfase
6.4.6. Laronidase
6.4.7. Others
Chapter 7. Global Enzyme Replacement Therapy Market, by Disease
7.1. Market Snapshot
7.2. Global Enzyme Replacement Therapy Market by Disease, Performance - Potential Analysis
7.3. Global Enzyme Replacement Therapy Market Estimates & Forecasts by Disease 2019-2029 (USD Billion)
7.4. Enzyme Replacement Therapy Market, Sub Segment Analysis
7.4.1. Gaucher Disease
7.4.2. Fabry Disease
7.4.3. Pompe Disease
7.4.4. Mucopolysaccharidosis
7.4.5. Exocrine Pancreatic Insufficiency (EPI)
7.4.6. Others
Chapter 8. Global Enzyme Replacement Therapy Market, by End User
8.1. Market Snapshot
8.2. Global Enzyme Replacement Therapy Market by End User, Performance - Potential Analysis
8.3. Global Enzyme Replacement Therapy Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Enzyme Replacement Therapy Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Infusion Centers & Home Healthcare Setting
Chapter 9. Global Enzyme Replacement Therapy Market, Regional Analysis
9.1. Enzyme Replacement Therapy Market, Regional Market Snapshot
9.2. North America Enzyme Replacement Therapy Market
9.2.1. U.S. Enzyme Replacement Therapy Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Enzyme Replacement Therapy Market
9.3. Europe Enzyme Replacement Therapy Market Snapshot
9.3.1. U.K. Enzyme Replacement Therapy Market
9.3.2. Germany Enzyme Replacement Therapy Market
9.3.3. France Enzyme Replacement Therapy Market
9.3.4. Spain Enzyme Replacement Therapy Market
9.3.5. Italy Enzyme Replacement Therapy Market
9.3.6. Rest of Europe Enzyme Replacement Therapy Market
9.4. Asia-Pacific Enzyme Replacement Therapy Market Snapshot
9.4.1. China Enzyme Replacement Therapy Market
9.4.2. India Enzyme Replacement Therapy Market
9.4.3. Japan Enzyme Replacement Therapy Market
9.4.4. Australia Enzyme Replacement Therapy Market
9.4.5. South Korea Enzyme Replacement Therapy Market
9.4.6. Rest of Asia Pacific Enzyme Replacement Therapy Market
9.5. Latin America Enzyme Replacement Therapy Market Snapshot
9.5.1. Brazil Enzyme Replacement Therapy Market
9.5.2. Mexico Enzyme Replacement Therapy Market
9.5.3. Rest of Latin America Enzyme Replacement Therapy Market
9.6. Rest of The World Enzyme Replacement Therapy Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbvie Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Astrazeneca Plc
10.2.3. Biomarin Pharmaceutical In
10.2.4. Chiesi Farmaceutici S.P.A.
10.2.5. Digestive Care, Inc.
10.2.6. Leadiant Biosciences, Inc.
10.2.7. Nestle Health Science
10.2.8. Pfizer Inc.
10.2.9. Sanofi S.A.
10.2.10. Takeda Pharmaceuticals
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption